February 21-22, 2023
London, UK
Booth #22
Visit Premier Research at booth 22 at COG. COG UK brings together senior decision-makers from across the spectrum of UK trial sponsors to hear from thought leaders within industry, regulator and academia alongside a group of the most trusted and innovative solution providers serving the UK market for two days of leading multi-stream agenda content and networking.
Separating the Good from the Great: Tips for Evaluating a CRO for Special Patient Populations
February 21st, 2:15 P.M.
Speaker: Anthony Poynton, Executive Director, Program Delivery, Rare Disease
Small patient populations. Limited data on disease. Patient enrollment and retention challenges. Narrow site pools. These are some of the most common hurdles sponsors face in rare disease drug development. The right CRO partner can help turn these challenges into solutions.
This presentation identifies the key criteria sponsors should consider when evaluating a CRO for a rare disease study, and what separates the good from the great. Topics will include:
- Assessing the CRO’s knowledge of the patient population
- Verifying the CRO’s understanding of your regulatory needs
- Interpreting the CRO’s strategy and the key questions you should be asking